Thomas W. Flaig, MD, University of Colorado Cancer Center member, presented critical updates to the NCCN Clinical Practice Guidelines in Oncology at the 30th Annual Conference. His insights focused on new treatment strategies for bladder cancer, including novel immunotherapy combinations and revised systemic therapy approaches for muscle-invasive and metastatic disease.